phase 3

Cartoon of businessmen standing around a broken target
Biotech

Spine BioPharma misses primary endpoint in back pain phase 3

With the biotech pinning the flop on a “very high sham control response,” management plans to meet with the FDA to discuss a potential path to market.
Nick Paul Taylor Aug 1, 2025 10:24am
Whale swimming in ocean seen from above

Merck wades deeper into HIV PrEP waters with pair of trials

Jul 14, 2025 1:12pm
Goal disorientation and lack of vision

UPDATED: Taiho’s discontinues ph. 3 trial after DMD miss

Jul 8, 2025 10:17am
Make a delay and accumulation of outstanding tasks Full stop

FDA delays force Daré to shelve phase 3 plans: WSJ

Apr 17, 2025 3:03pm
whale jumping out of water

Orca prepares to make market plunge after phase 3 win

Mar 17, 2025 7:00am
boat cutting through water

Amgen’s late-stage obesity trials expected to read out in ‘27

Mar 5, 2025 1:58pm